Anonymous ID: 713288 Sept. 7, 2023, 12:18 p.m. No.19507604   🗄️.is 🔗kun   >>7784 >>7973 >>8043 >>8135

https://www.pravda.com.ua/eng/news/2023/09/6/7418741/

https://archive.ph/wip/EeoQ1

 

Ukraine will use depleted uranium shells responsibly – Pentagon

 

The United States is confident that Ukrainians will use depleted uranium ammunition responsibly.

 

Source: European Pravda, citing Sabrina Singh, US Department of Defence spokeswoman, in an interview with CNN

 

Details: Commenting on reports of the provision of depleted uranium shells to Kyiv even before the Pentagon announced this, she stressed that these ammunitions are standard for tanks used by the United States and which Ukraine will receive.

"We have absolute confidence that the Ukrainians will use them responsibly as they fight to take back their sovereign territory," Singh said.

 

 

Sauce:

https://edition.cnn.com/europe/live-news/russia-ukraine-war-news-09-06-23/h_05a82ea8660bb9974939b8addf5c1d5d

https://archive.ph/j8R2A

US expected to announce depleted uranium munitions for Ukraine, official says

 

Deputy Pentagon press secretary Sabrina Singh told CNN on Wednesday that the US is confident the Ukrainians would use the munitions responsibly if and when they are provided.

“I’m not going to get ahead of any announcements that the Pentagon hasn’t made yet today, but what I will say is these rounds are standard use in the tanks that not only the US uses, but that we will be providing the Ukrainians. And if they are included in the packages that are coming forward today or in the coming weeks, we have absolute confidence that the Ukrainians will use them responsibly as they fight to take back their sovereign territory in the east and the north, as well,” she said.

Anonymous ID: 713288 Sept. 7, 2023, 1:38 p.m. No.19508093   🗄️.is 🔗kun   >>8097

>>19508086

>>19507903

also full text:

 

U.S. officials are refusing to provide COVID-19 vaccine safety data to a U.S. senator.

Sen. Ron Johnson (R-Wis.) asked the U.S. Food and Drug Administration (FDA) for the results of analyses on data from the Vaccine Adverse Event Reporting System in January. The request came after the U.S. Centers for Disease Control and Prevention (CDC) said none of the safety signals it identified for the COVID-19 vaccines were "unexpected."

The two agencies have run different types of analyses on the system's reports, which are primarily made by health care professionals.

The CDC ran Proportional Reporting Ratio analyses, which involve comparing the number of reported adverse events to the number of adverse events reported after vaccination with other vaccines.

The first time the agency ran analyses using the method for the COVID-19 vaccines, in 2022, hundreds of signals were triggered, files obtained by The Epoch Times show.

The FDA in 2021 started a different type of analysis, called Empirical Bayesian (EB) data mining.

The Proportional Reporting Ratio results “were generally consistent with EB data mining, revealing no additional unexpected safety signals," Dr. Rochelle Walensky, the CDC's director at the time, told Mr. Johnson previously.

Mr. Johnson demanded answers on that claim, prompting the CDC to point him to the FDA.

The FDA recently responded to Mr. Johnson, telling him that it cannot provide the information he seeks.

"FDA’s EB data mining analyses of adverse events contained in VAERS reports for COVID-19 vaccines are currently the subject of pending FOIA [Freedom of Information Act] litigation. FDA is unable to comment on pending litigation or provide information or data that is currently being considered in pending litigation," the agency told the senator.

Mr. Johnson in a new letter told FDA Commissioner Dr. Robert Califf that the claim was wrong.

"As you are well aware, Congress has a right to information contained at U.S. federal agencies as it conducts its constitutional oversight responsibilities," Mr. Johnson said.

"It is outrageous that FDA would assert that pending litigation, and particularly FOIA litigation, would allow your agency to obstruct my congressional oversight," he added. "Any pending litigation FDA may have relating to its EB data mining records has no bearing on its responsibility to comply with a congressional request."

Mr. Johnson said in the past he's repeatedly received from the government documents subject to litigation, including from the FDA's parent agency, the U.S. Department of Health and Human Services (HHS).

He urged the FDA to produce the EB data mining analyses by Sept. 20.

The FDA declined to immediately provide a comment.